Pharmaceutical Product Development (PPD), a Wilmington, North Carolina-headquartered contract research organization, and Quotient Sciences, a Nottingham, UK-based contract development and manufacturing organization, have partnered in pediatric drug development.

The partnership will use PPD’s pediatric clinical trial experience, regulatory knowledge, and site and pediatric patient networks, and Quotient’s expertise in pediatric formulation development, drug-product manufacturing, and global supplies. The companies plan to jointly support pediatric drug development from concept to market launch through an end-to-end service that is designed to speed delivery of pediatric medicines.

Quotient says it has created an approach to drug development called Translational Pharmaceutics that integrates formulation development, real-time adaptive GMP manufacturing, and clinical research capabilities to reduce drug-development costs and shorten timelines.

Source: Quotient Sciences